Home > Cashflow Statement > INDO US BIOTECH

INDO US BIOTECH
Cash Flow from Financing Activities

    Back to Cashflow Statement
COMMUNITY POLL
for INDO US BIOTECH
Please provide your vote to see the results

INDO US BIOTECH Last 5 Year Cash Flow from Financing Activities History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Financing Activities ₹1.22 Cr₹6.29 Cr₹2.41 Cr₹1.46 Cr₹1.53 Cr

What is the latest Cash Flow from Financing Activities ratio of INDO US BIOTECH ?

The latest Cash Flow from Financing Activities ratio of INDO US BIOTECH is ₹1.22 Cr based on Mar2024 Standalone results.
Year Cash Flow from Financing Activities
Mar2024₹1.22 Cr
Mar2023₹6.29 Cr
Mar2022₹2.41 Cr
Mar2021₹1.46 Cr
Mar2020₹1.53 Cr

How is Cash Flow from Financing Activities of INDO US BIOTECH Trending?

Years Cash Flow from Financing Activities % Change
Mar2024 ₹1.22 Cr
-80.68
Mar2023 ₹6.29 Cr
160.95
Mar2022 ₹2.41 Cr
64.96
Mar2021 ₹1.46 Cr
-4.38
Mar2020 ₹1.53 Cr -

Compare Cash Flow from Financing Activities of peers of INDO US BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDO US BIOTECH ₹308.6 Cr 1.5% 1.6% -27% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹12,934.7 Cr -5.8% -6.3% 14.7% Stock Analytics
KAVERI SEED COMPANY ₹6,436.8 Cr -5.7% -15.3% 32.9% Stock Analytics
VENKYS (INDIA) ₹2,264.3 Cr -1.5% 0.4% -16.7% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,435.5 Cr -2% -1.8% -33.7% Stock Analytics
MANGALAM GLOBAL ENTERPRISE ₹481.8 Cr 3.5% 11.2% NA Stock Analytics


INDO US BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDO US BIOTECH

1.5%

1.6%

-27%

SENSEX

1.6%

1%

7%


You may also like the below Video Courses